Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study.

MLA

Vela, Carla, et al. “Conversion to MTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study.” Journal of Clinical Medicine, vol. 11, no. 24, Dec. 2022. EBSCOhost, https://doi.org/10.3390/jcm11247292.

APA

Vela, C., Jouve, T., Chevallier, E., Imerzoukene, F., Germi, R., Le Marechal, M., Truffot, A., Fiard, G., Janbon, B., Giovannini, D., Malvezzi, P., Rostaing, L., & Noble, J. (2022). Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study. Journal of Clinical Medicine, 11(24). https://doi.org/10.3390/jcm11247292

Chicago

Vela, Carla, Thomas Jouve, Eloi Chevallier, Farida Imerzoukene, Raphaële Germi, Marion Le Marechal, Aurélie Truffot, et al. 2022. “Conversion to MTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study.” Journal of Clinical Medicine 11 (24). doi:10.3390/jcm11247292.